title: Molecular characterization of noroviruses and HBGA from infected Quilombola children in Espirito Santo State, Brazil.
abstract: Noroviruses (NoV) are the main etiological agents of gastroenteritis outbreaks worldwide and susceptibility to NoV infection has been related to the histo-blood group antigen (HBGA). This study aimed to determine the prevalence of NoV strains and to evaluate the HBGA phenotype and genotype of children from semi-isolated Quilombola communities, descendents of black slaves in Brazil. A total of 397 children up to eleven years old, with and without diarrhea, from Quilombola Communities in the Espirito Santo State, Brazil, were investigated for the presence of NoV from August 2007 to September 2009. Feces were collected from all the children, and blood from the NoV positive children. NoV was screened by reverse transcription-PCR with primers for the RNA-dependent RNA polymerase region; genogroup was determined by PCR with primers for the C and D regions and genotyped by sequencing. HBGA phenotype was performed by gel-spinning and FUT2 and FUT3 were analyzed by PCR or sequencing analysis. NoV were detected in 9.2% (12/131) of diarrheic and 1.5% (4/266) of non-diarrheic children (p<0.05, Fisher's exact test). GI and GII genogroups were present in 12.5% and 87.5% of the samples, respectively. The following genotypes were characterized: GII.4 (25%), GII.12 (25%), GII.6 (12.5%) and GI.1 (6.3%), GI.3 (12.5%) and GI.4 (6.3%). Children infected with NoV showed the A (n = 6), O (n = 6), and B (n = 2) HBGA phenotypes, and 13 of them were classified as secretors (Se) and one as a non secretor (se). Mutations of Se (40), (171,216,357,428,739,960) were found for the FUT2 gene and mutations of Le (59, 202, 314) for the FUT3 gene. The only se child was infected by NoV GI, whereas the Se children were indiscriminately infected by GI or GII. This study showed rates of NoV infection in symptomatic and asymptomatic Quilombola children consistent with other studies. However, children under 12 months were seven times more affected than those between 1 and 5 years old. GII.12 was as frequent as GII.4 and GI.1 and GI.4 were described for the first time in Brazil. Owing to the small number of cases studied, no clear pattern of susceptibility and/or HBGA resistance could be inferred.
authors.affiliation: Departamento de Ciências da Saúde, Universidade Federal do Espírito Santo, São Mateus, Espírito Santo, Brazil. fernandovicentini@ceunes.ufes.br
authors.forename: Fernando
authors.initials: F
authors.lastname: Vicentini
authors.forename: Wilson
authors.initials: W
authors.lastname: Denadai
authors.forename: Yohanna Mayelle
authors.initials: YM
authors.lastname: Gomes
authors.forename: Tatiana L
authors.initials: TL
authors.lastname: Rose
authors.forename: Mônica S R
authors.initials: MS
authors.lastname: Ferreira
authors.forename: Beatrice
authors.initials: B
authors.lastname: Le Moullac-Vaidye
authors.forename: Jacques
authors.initials: J
authors.lastname: Le Pendu
authors.forename: José Paulo Gagliardi
authors.initials: JP
authors.lastname: Leite
authors.forename: Marize Pereira
authors.initials: MP
authors.lastname: Miagostovich
authors.forename: Liliana Cruz
authors.initials: LC
authors.lastname: Spano
mesh_terms: D001789:Blood Group Antigens / Q000235:genetics*; D001938:Brazil / Q000453:epidemiology / Q000208:ethnology; D017250:Caliciviridae Infections / Q000097:blood* / Q000453:epidemiology* / Q000208:ethnology / Q000235:genetics; D002648:Child; D003967:Diarrhea / Q000150:complications; D005647:Fucosyltransferases / Q000235:genetics; D005759:Gastroenteritis / Q000097:blood* / Q000453:epidemiology* / Q000208:ethnology / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D029322:Norovirus / Q000302:isolation & purification* / Q000502:physiology*; D010641:Phenotype; D011110:Polymorphism, Genetic; D015995:Prevalence; D000097631:Galactoside 2-alpha-L-fucosyltransferase
chemical_list: D001789:Blood Group Antigens; D005647:Fucosyltransferases; D000097631:Galactoside 2-alpha-L-fucosyltransferase; C019818:3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase
references.citation: J Clin Virol. 2010 Jan;47(1):60-4
references.pmid: 20004146
references.citation: Glycoconj J. 2009 Dec;26(9):1171-80
references.pmid: 19387828
references.citation: J Med Virol. 2003 Apr;69(4):568-78
references.pmid: 12601766
references.citation: J Infect Dis. 2003 Jul 1;188(1):19-31
references.pmid: 12825167
references.citation: Tissue Antigens. 1997 Nov;50(5):475-83
references.pmid: 9389321
references.citation: Euro Surveill. 2013 Jan 10;18(2):
references.pmid: 23324428
references.citation: J Virol. 2011 Sep;85(17):8656-66
references.pmid: 21715504
references.citation: Mem Inst Oswaldo Cruz. 2011 Dec;106(8):907-11
references.pmid: 22241109
references.citation: J Med Virol. 2004 May;73(1):113-7
references.pmid: 15042657
references.citation: Mol Biol Evol. 2009 Sep;26(9):1993-2003
references.pmid: 19487333
references.citation: Appl Environ Microbiol. 2002 Apr;68(4):1925-31
references.pmid: 11916714
references.citation: J Med Virol. 2008 Jul;80(7):1296-301
references.pmid: 18461617
references.citation: J Virol Methods. 2002 Feb;100(1-2):107-14
references.pmid: 11742657
references.citation: Arch Virol. 2010;155(1):111-5
references.pmid: 19949962
references.citation: Emerg Infect Dis. 2008 Aug;14(8):1224-31
references.pmid: 18680645
references.citation: Emerg Infect Dis. 2010 Jan;16(1):81-7
references.pmid: 20031047
references.citation: Glycobiology. 2009 Mar;19(3):309-20
references.pmid: 19054801
references.citation: Gastroenterology. 2002 Jun;122(7):1967-77
references.pmid: 12055602
references.citation: Nat Med. 2003 May;9(5):548-53
references.pmid: 12692541
references.citation: Genetics. 2001 Jun;158(2):747-56
references.pmid: 11404338
references.citation: J Virol Methods. 2004 Mar 15;116(2):109-17
references.pmid: 14738976
references.citation: Mem Inst Oswaldo Cruz. 2011 Dec;106(8):942-7
references.pmid: 22241115
references.citation: J Med Virol. 2007 May;79(5):544-51
references.pmid: 17385696
references.citation: J Virol. 2002 Dec;76(23):12335-43
references.pmid: 12414974
references.citation: Arch Virol. 2012 Dec;157(12):2389-92
references.pmid: 22872050
references.citation: Nat Rev Microbiol. 2010 Mar;8(3):231-41
references.pmid: 20125087
references.citation: Emerg Infect Dis. 2011 Aug;17(8):1516-8
references.pmid: 21801639
references.citation: Nucleic Acids Res. 2012 Jan;40(Database issue):D1023-9
references.pmid: 22084196
references.citation: J Virol. 2005 Jun;79(11):6714-22
references.pmid: 15890909
references.citation: Emerg Infect Dis. 2007 Aug;13(8):1244-6
references.pmid: 17953103
references.citation: J Med Virol. 1997 Dec;53(4):372-83
references.pmid: 9407386
references.citation: J Biol Chem. 1995 Mar 3;270(9):4640-9
references.pmid: 7876235
references.citation: J Virol. 1992 Nov;66(11):6527-32
references.pmid: 1328679
references.citation: J Infect Dis. 2009 Sep 1;200(5):802-12
references.pmid: 19627248
references.citation: J Clin Microbiol. 1990 Mar;28(3):495-503
references.pmid: 1691208
references.citation: J Med Virol. 2009 Apr;81(4):728-35
references.pmid: 19235844
references.citation: J Virol. 2011 May;85(9):4057-70
references.pmid: 21345963
references.citation: Am J Infect Control. 2013 Jul;41(7):654-7
references.pmid: 23266383
references.citation: J Biochem Toxicol. 1994 Aug;9(4):191-8
references.pmid: 7853353
references.citation: Hum Mutat. 2001 Oct;18(4):358-9
references.pmid: 11668626
references.citation: N Engl J Med. 2009 Oct 29;361(18):1776-85
references.pmid: 19864676
references.citation: PLoS One. 2012;7(7):e41625
references.pmid: 22844506
references.citation: Biochimie. 2001 Jul;83(7):565-73
references.pmid: 11522384
references.citation: PLoS Med. 2008 Feb;5(2):e31
references.pmid: 18271619
references.citation: PLoS One. 2012;7(3):e33754
references.pmid: 22448271
references.citation: Trends Microbiol. 2011 May;19(5):233-40
references.pmid: 21310617
references.citation: PLoS One. 2013;8(2):e56608
references.pmid: 23457593
references.citation: J Virol. 2005 Dec;79(24):15351-5
references.pmid: 16306606
references.citation: Infect Genet Evol. 2009 Sep;9(5):927-32
references.pmid: 19559104
references.citation: J Med Virol. 2005 Sep;77(1):116-20
references.pmid: 16032732
references.citation: J Virol. 2012 Oct;86(20):11138-50
references.pmid: 22855491